Concepedia

Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients

Shigeo Tamura, Kazue Ueki, Keiichi Mashimo, Yoshito Tsukada, Miyuki Naitoh, Yukiko Abe, Hironobu Kawai, Akiyasu Tsuchida, Ryoji Wakamatsu, Yoshihisa Nojima

Clinical and Experimental Nephrology · 2005 · 13 citations · 14 references

DOI

Concepts

References

14

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

Shaul G. Massry, Jack W. Coburn, Glenn M. Chertow et al. · Data Archiving and Networked Services (DANS) · 2003 · 2.5K citations

, , +16

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study

GA Block, TE Hulbert-Shearon, Levin Nw et al. · American Journal of Kidney Diseases · 1998 · 2.4K citations

, , +16

Bone metabolism and disease in chronic kidney disease

Garabed Eknoyan, Adeera Levin, Nathan W. Levin · American Journal of Kidney Diseases · 2003 · 1.3K citations

, , +14

Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol Therapy

Ming Teng, Myles Wolf, Edmund G. Lowrie et al. · New England Journal of Medicine · 2003 · 926 citations · Full text

, , +17

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

Eduardo Slatopolsky, Carol Weerts, J Thielan et al. · Journal of Clinical Investigation · 1984 · 686 citations · Full text

, , +15